Canadian trademark · application 2373874
AUGTYRO
PendingFiled, waiting for examination
- Status at CIPO
- Formalized
- Filed
- January 10, 2025
- Registered
- Not yet
- Kind of mark
- Design (words shown are those in the design)
- Classes
- 5 Pharmaceuticals
What it covers
The start of the goods and services, for up to three classes. The full list is on CIPO's record.
- Class 5 (Pharmaceuticals)Pharmaceutical preparations for the treatment of cancer
Other marks named AUGTYRO
The same name can be held by different owners for different goods. Every mark named AUGTYRO →
| Mark | Owner | Classes | Standing | Year |
|---|---|---|---|---|
| AUGTYRO 2207466 · TMA1227416 | Turning Point Therapeutics, Inc. | 5 Pharmaceuticals | Registered | 2024 |
Similar marks
Live marks that sound the same, contain the name, are spelled close, or share its least common word. Not a finding that any of them conflicts with this one.
More from Turning Point Therapeutics, Inc.
All of Turning Point Therapeutics, Inc.'s marks →
| Mark | Classes | Standing | Year |
|---|---|---|---|
| AUGTYROS 2269707 | 5 Pharmaceuticals | Pending | 2023 |
| TULKROSSI 2264612 | 5 Pharmaceuticals | Pending | 2023 |
| TULKROSI 2264610 | 5 Pharmaceuticals | Pending | 2023 |
| CELROSFI 2264536 | 5 Pharmaceuticals | Pending | 2023 |
| NYXTROSI 2264535 | 5 Pharmaceuticals | Pending | 2023 |
| BESJEVIDY 2264534 | 5 Pharmaceuticals | Pending | 2023 |
| NYXROSSY 2264533 | 5 Pharmaceuticals | Pending | 2023 |
| ROSJEVIDY 2264532 | 5 Pharmaceuticals | Pending | 2023 |
This shows what is on the Canadian trademark register and what looks or sounds similar. It is not legal advice and not a clearance search: it cannot say whether a name is safe to use or would conflict with another mark. A trademark agent can.
Register as of January 22, 2025: CIPO's latest public data release (Open Government Licence – Canada). Marks filed or changed since then are not here yet. Check the current record on CIPO's own database before relying on it.
Application 2373874 · 1 classes · data from CIPO